Biogen Inc. buy Needham & Company LLC
Start price
26.07.24
/
50%
€194.45
Target price
26.07.25
€270.72
Performance (%)
-8.15%
Price
20.09.24
€178.60
Summary
This prediction is currently active. With a performance of -8.15%, the BUY prediction by Needham___Company_LL is trending in the wrong direction. This prediction currently runs until 26.07.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 1.133% | 1.133% |
iShares Core DAX® | 0.347% | 2.173% |
iShares Nasdaq 100 | 0.715% | 0.138% |
iShares Nikkei 225® | 1.522% | 2.003% |
iShares S&P 500 | 0.631% | 1.633% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $294.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat